1,300
Participants
Start Date
February 21, 2022
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Rivaroxaban Oral Tablet
For 12months, Rivaroxaban oral tablet 20mg once daily For renal disorder subjects\_creatinine clearance 15-49 mL/min, 15mg once daily
Vitamin K antagonist(warfarin)
For 12months, keep the international normalized ratio (INR) 1.7-3.0
RECRUITING
Buchen Sejong Hospital, Bucheon-si
RECRUITING
Dong-A University Hospital, Busan
RECRUITING
Keimyung University Dongsan Hospital, Daegu
RECRUITING
GangNeung Asan Hospital, Gangneung
RECRUITING
Chonnam National University Hospital, Gwangju
RECRUITING
Korea University Anam Hospital, Seoul
RECRUITING
Samsung Medical Center, Seoul
RECRUITING
Seoul National University Hospital, Seoul
NOT_YET_RECRUITING
Ulsan University Hospital, Ulsan
RECRUITING
Pusan National University Yangsan Hospital, Yangsan
RECRUITING
Asan Medical Center, Seoul
Joon Bum Kim
OTHER